30 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva launches generic Ranexa in U.S. https://seekingalpha.com/news/3467223-teva-launches-generic-ranexa-u-s?source=feed_news_all May 28, 2019 - Teva Pharmaceutical Industries (TEVA -12.9%) commences the U.S. commercial launch of its generic version of Gilead Sciences' (GILD -3.2%) angina med Ranexa (ranolazine) Extended-Release Tablets, 500 m
Why Teva Pharmaceutical Industries, Seadrill, and Nutanix Slumped Today https://www.fool.com/investing/2019/05/28/why-teva-pharmaceutical-industries-seadrill-and-nu.aspx?source=iedfolrf0000001 May 28, 2019 - Tough industry conditions took their toll on some stocks.
Teva Settles With Oklahoma, Shares Fall Following Downgrade http://www.zacks.com/stock/news/421544/teva-settles-with-oklahoma-shares-fall-following-downgrade?cid=CS-ZC-FT-421544 May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
Company News For May 29, 2019 http://www.zacks.com/stock/news/421315/company-news-for-may-29-2019?cid=CS-ZC--421315 May 29, 2019 - Companies in the news are: UBER, TEVA, AMD and ASGN
Lilly's Emgality Gets FDA Approval for Cluster Headache http://www.zacks.com/stock/news/425463/lillys-emgality-gets-fda-approval-for-cluster-headache?cid=CS-ZC-FT-425463 Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Celgene's Filing for Ozanimod Accepted for Review in US/EU http://www.zacks.com/stock/news/426482/celgenes-filing-for-ozanimod-accepted-for-review-in-us-eu?cid=CS-ZC-FT-426482 Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know http://www.zacks.com/stock/news/429353/teva-pharmaceutical-industries-ltd-teva-stock-sinks-as-market-gains-what-you-should-know?cid=CS-ZC-FT-429353 Jun 13, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.62 in the latest trading session, marking a -1.03% move from the prior day.
Here are the biggest analyst calls of the day: Disney, Deere, Apple, Keurig Dr. Pepper & more https://www.cnbc.com/2019/06/17/calls-of-the-day-disney-deere-apple-more.html Jun 17, 2019 - Here are the biggest calls on Wall Street on Monday
Price Fixing Lawsuits And Opioid Litigation Shouldn't Deliver A Killing Blow To Teva - 100% Upside https://seekingalpha.com/article/4270785-price-fixing-lawsuits-opioid-litigation-deliver-killing-blow-teva-100-percent-upside?source=feed_tag_israel Jun 18, 2019 - TEVA's generic revenues are surprisingly resilient against Medicare reform.The company's top notch pipeline and product launches have the ability to offset the generic drug apocalypse.Investor capitul
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know http://www.zacks.com/stock/news/432456/teva-pharmaceutical-industries-ltd-teva-stock-sinks-as-market-gains-what-you-should-know?cid=CS-ZC-FT-432456 Jun 20, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.12 in the latest trading session, marking a -0.73% move from the prior day.

Pages: 123

<<<Page 3